Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients

The effectiveness of ceftolozane/tazobactam for the treatment of infections in neutropenic patients caused by hypervirulent multidrug-resistant (MDR) Pseudomonas aeruginosa has not been previously reported. We identified seven cases of MDR P. aeruginosa infection in neutropenic patients over a four-...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Paolo E., Gaibani, Paolo, Sartor, Chiara, Ambretti, Simone, Lewis, Russell E., Sassi, Claudia, Pignatti, Marco, Paolini, Stefania, Curti, Antonio, Castagnetti, Fausto, Ursi, Margherita, Cavo, Michele, Stanzani, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767535/
https://www.ncbi.nlm.nih.gov/pubmed/33371496
http://dx.doi.org/10.3390/microorganisms8122055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767535/
https://www.ncbi.nlm.nih.gov/pubmed/33371496
http://dx.doi.org/10.3390/microorganisms8122055

Ejemplares similares